Rasagiline Tablets (Rasagiline Mesylate)

Adult dose

This medicine is administered orally to adults once daily as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy to a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy to levodopa: The recommended initial dose for patients taking levodopa is 0.5mg once daily. If well tolerated and an adequate clinical response is not achieved, the dose may be increased to 1mg once daily. This medicine may be taken with or without food.

This medication should not be administered to patients who are allergic to the active ingredient or any other components. Patients currently taking or who have stopped other MAO inhibitors or herbal medicines within the last two weeks should not use this medication. Patients currently taking or who have stopped certain medications such as meperidine, tramadol, and dextromethorphan within the last two weeks should also refrain from using this medication. Patients with moderate to severe liver impairment should not take this medication, and those with mild liver impairment should use it cautiously. During the use of this medication, various adverse reactions such as headache, dizziness, nausea, insomnia, arthralgia, skin rash, appetite loss, hallucinations, and depression may occur, and if symptoms are severe, consultation with a physician is advised. Particularly in Parkinson's disease patients, hallucinations, confusion, increased blood pressure, impulse control disorders, drowsiness, and sudden sleep attacks may occur, necessitating caution. This medication may cause serious side effects when used in combination with other antidepressants, sympathomimetics, or certain analgesics, so consultation with a doctor or pharmacist is essential. Women who are pregnant or breastfeeding should be cautious when using this medication, and its safety in children has not been established. This medication may affect the ability to drive or operate machinery; therefore, if drowsiness or sudden sleep attacks occur, such activities should be avoided. In case of overdose, dangerous symptoms such as severe hypertension or serotonin syndrome may occur, so the prescribed dosage must be strictly followed. This medication should be stored out of the reach of children and kept in a sealed container to prevent air and moisture ingress, ideally in a cool place at a temperature between 1°C and 25°C.

• Influenza
• skin cancer
• leukopenia
• allergy
• decreased appetite
• depression
• hallucination
• headache
• cerebrovascular accident
• conjunctivitis

This medication should be stored in a tightly sealed container to prevent air and moisture ingress, ideally kept in a cool place at a temperature between 1°C and 25°C. Storing this way will help maintain the effectiveness of the medication for a longer period.

Appearance

White round tablets

Package unit

30 tablets/PTP [10 tablets/PTP*3], 30 tablets/bottle